CRVS
Corvus Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Corvus Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Corvus Pharmaceuticals, Inc.
9.79
−0.78 · −7.41%
post 9.79 +0.03%
No thesis.
Largest filed tie
—
News
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Orbimed AdvisorsOrbimed | $107.0M | 9.83% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $106.7M | 9.80% | +15.88% | |
| 3 | State StreetState Streetindex-like | $66.8M | 6.14% | +25.47% | |
| 4 | T. Rowe Price AssociatesT. Rowe Price | $56.6M | 5.20% | +29.88% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $49.2M | 4.52% | +1.80% | |
| 6 | Adams Street PartnersAdams Street Partners | $48.9M | 4.49% | 0.00% | |
| 7 | Vivo CapitalVivo Capital | $41.9M | 3.85% | 0.00% | |
| 8 | Wellington Management GroupWellington | $40.8M | 3.75% | +17.82% | |
| 9 | Perceptive AdvisorsPerceptive | $39.9M | 3.66% | +16.36% | |
| 10 | Deep Track CapitalDeep Track Capital | $37.2M | 3.42% | +0.02% | |
| 11 | BraidwellBraidwell | $31.8M | 2.92% | +21.31% | |
| 12 | Geode Capital ManagementGeodeindex-like | $27.7M | 2.54% | +8.23% | |
| 13 | Foresite Capital Management VIForesite Capital Management VI | $27.4M | 2.51% | 0.00% | |
| 14 | Goldman Sachs GroupGoldman Sachs | $23.6M | 2.16% | +2.31% | |
| 15 | Hood River Capital ManagementHood River | $23.5M | 2.16% | +17.73% | |
| 16 | Morgan StanleyMorgan Stanley | $20.1M | 1.85% | −46.19% | |
| 17 | Boxer Capital ManagementBoxer | $16.4M | 1.51% | 0.00% | |
| 18 | Catalio Capital ManagementCatalio | $16.1M | 1.48% | +21.18% | |
| 19 | Susquehanna International GroupSusquehanna International | $15.7M | 1.44% | +36.66% | |
| 20 | Millennium ManagementMillennium | $15.7M | 1.44% | +20.96% | |
| 21 | Citadel AdvisorsCitadel | $15.6M | 1.43% | +14.26% | |
| 22 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $12.2M | 1.12% | +21.62% | |
| 23 | Two Sigma InvestmentsTwo Sigma | $11.7M | 1.08% | +45.44% | |
| 24 | Bank of AmericaBank of America | $11.3M | 1.04% | +219.74% | |
| 25 | Adage Capital Partners GPAdage Capital Partners GP | $11.2M | 1.03% | 0.00% |
173 managers report $1.1B of Corvus Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; Orbimed is largest at 9.83%.
Expected move
No implied move.
No implied move.
No implied move.